DOI QR코드

DOI QR Code

Anti-Helicobacter pylori Activity of Korean Propolis

국산 프로폴리스의 Helicobacter pyrori 억제효과

  • Han, Sang Mi (Dept. of Agricultural Biology, National Academy of Agricultural Science) ;
  • Hong, In Phyo (Dept. of Agricultural Biology, National Academy of Agricultural Science) ;
  • Woo, Soon Ok (Dept. of Agricultural Biology, National Academy of Agricultural Science) ;
  • Kim, Se Gun (Dept. of Agricultural Biology, National Academy of Agricultural Science) ;
  • Jang, Hye Ri (Dept. of Agricultural Biology, National Academy of Agricultural Science) ;
  • Jang, Jae Seon (Dept. of Food & Nutrition, Gachon University)
  • 한상미 (국립농업과학원 농업생물부 잠사양봉소재과) ;
  • 홍인표 (국립농업과학원 농업생물부 잠사양봉소재과) ;
  • 우순옥 (국립농업과학원 농업생물부 잠사양봉소재과) ;
  • 김세건 (국립농업과학원 농업생물부 잠사양봉소재과) ;
  • 장혜리 (국립농업과학원 농업생물부 잠사양봉소재과) ;
  • 장재선 (가천대학교 식품영양학과)
  • Received : 2015.12.24
  • Accepted : 2016.02.22
  • Published : 2016.02.29

Abstract

Propolis possesses antimicrobial, anti-inflammatory, anaesthetic and immunostimulating activities. The aim of this study was to evaluated chemical composition and in vitro anti-Helicobacter pylori activity of eight propolis ethanolic extracts form different region in Korea. The chemical composition of eight Korean propolis was investicated by absorption spectrophotomety and UHPLC. Total penolic and total flavonoids content ranged between $21{\pm}1.5$ and $31{\pm}1.8$ gallic acid g/100 g and $7.2{\pm}0.9$ and $24.4{\pm}1.9$ quercetin g/100 g, respectively. The p-coumaric acid as standard components content ranged between $0.29{\pm}0.00$ and $2.34{\pm}0.02mg/g$ using UHPLC. Cinnamic acid content between $0.43{\pm}0.00$ and $1.33{\pm}0.01mg/g$. 80% ethanolic extract of propolis against H. pylori was evaluated by using the disc diffusion method. Ethanol was used as a control. Mean diameters of H. pylori growth inhibition using $10{\mu}g/mL$, $50{\mu}g/mL$ or $100{\mu}g/mL$ ethanol propolis per disc were 0, ranging from 0.9 to 2.1 mm and from 1.9 to 3.5 mm, respectively. In conclusion, variation in the chemical composition of Korean propolis were mainly due to the difference in the preferred regional plants visited by honeybees. Also Korean propolis possesses considerable antibacterial activity against H. pylori. There was not confirmed a correlation between the chemical composion contens and anti-H. pylori effect. The potential of propolis in the prevention or treatment of H. pylori infection is worth further extensive evaluation.

Keywords

References

  1. Ayala G, Escobedo-Hinojosa WI, de la Cruz-Herrera CF, Romero I. 2014. Exploring alternative treatments for Helicobacter pylori infection. World J Gastroenterol 20:1450-1469 https://doi.org/10.3748/wjg.v20.i6.1450
  2. Bankova V, Popova M, Trusheva B. 2014. Propolis volatile compounds: Chemical diversity and biological activity. Chem Cent J doi:10.1186/1752-153X-8-28
  3. Banskota AH, Tezuka Y, Kadota, S. 2001. Recent progress in pharmacological research of propolis. Phytother Res 15:561-571 https://doi.org/10.1002/ptr.1029
  4. Calderon-Montano JM, Burgos-Moron E, Perez-Guerrero C, Lopez-Lazaro M. 2011. A review on the dietary flavonoid kaempferol. Mini Rev Med Chem 11:298-344. https://doi.org/10.2174/138955711795305335
  5. Fearnley J. 2001. Bee Propolis. Souvenir Press, London, UK. pp. 10-132
  6. Goodwin CS, Armstron JA. 1990. Microbiological aspects of Helicobacter pylori (Campylobacter pylori). Eur J Clin Microbiol Infect Dis 9:1-13 https://doi.org/10.1007/BF01969526
  7. Guzman JD. 2014. Natural cinnamic acids, synthetic derivatives and hybrids with antimicrobial activity. Molecules 19:19292-19349 https://doi.org/10.3390/molecules191219292
  8. Kim NY, Kim JK, Kim JH, Kim HY, Kim SW, Kim JJ, Noh IH, Shim JK, Ahn HS, Yoon BC, Lee SW, Lee YC, Cheong IS, Cheong HY. 2000. Seroprevalence of Helicobacter pylori infection in asymptomatic people in Korea. Kor J Int Med 59:388-392
  9. Korea Food & Drug Administration. 2010. Health Functional Food Code. Osong, Korea. p II.2.2.3
  10. Kurek-Gorecka A, Rzepecka-Stojko A, Gorecki M, Stojko J, Sosada M, Swierczek-Zieba G. 2013. Structure and antioxidant activity of polyphenols derived from propolis. Molecules 19:78-101 https://doi.org/10.3390/molecules19010078
  11. Kuropatnicki AK, Szliszka E, Krol W. 2013. Historical aspects of propolis research in modern times. J Evid-Based Complementary Altern Med 2013:1-12
  12. Kusters JG, van Vliet AH, Kuipers EJ. 2006. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19: 449-490 https://doi.org/10.1128/CMR.00054-05
  13. Markham KE, Mitchel KA, Wilkin AL, Daldy JA, Lu Y. 1996. HPLC and GC-MS identification of the major organic constituents in New Zealand propolis. Phytochemistry 42:205-211 https://doi.org/10.1016/0031-9422(96)83286-9
  14. Misiewicz JJ, Harris AW, Bardhan KD, Levi S, O'Morain C, Cooper BT, Kerr GD, Dixon MF, Langworthy H, Piper D. 1997. One week triple therapy for Helicobacter pylori: A multicentr comparative study. Gut 41:735-739 https://doi.org/10.1136/gut.41.6.735
  15. National Committee for Clinical Laboratory Standards. 1992. Methods for Determining Bactericidal Activity of Antimicrobial Agents: Tentative Guideline M26-T. NCCLS, Wayne, PA, USA.
  16. Romano M, Iovene MR, Russo MI, Salerno R, Cozzolino D, Pilloni AP, Tufano MA, Vaira D, Nardone G. 2008. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial resistant Helicobacter pylori clinical isolates. J Clin Pathol 61:1112-1115 https://doi.org/10.1136/jcp.2008.060392
  17. Salatino A, Fernandes-Silva CC, Righi AA, Salatino ML. 2011. Propolis research and the chemistry of plant products. Nat Prod Rep 28:925-936 https://doi.org/10.1039/c0np00072h
  18. Silva-Carvalho R, Baltazar F, Almeida-Aguiar C. 2015. Propolis:A complex natural product with a plethora of biological activities that can be explored for drug development. Evid Based Complement Alternat Med doi:10.1155/2015/206439
  19. Spinzi GC, Boni F, Bortoli A, Colombo E, ballardini G, Venturelli R, Minoli G. 2000. Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentr, randomized, single-blind study. Aliment Pharmacol Ther 14:325-330 https://doi.org/10.1046/j.1365-2036.2000.00708.x
  20. Spooner FD, Sykes G. 1972. Laboratory assessment of antibacterial activity. In Norris JR, Ribbons DW. Methods in Microbiology, vol 7B. Academic Press, London, UK. pp. 52-150
  21. Suleman T, van Vuuren S, Sandasi M, Viljoen AM. 2015. Antimicrobial activity and chemometric modelling of South African propolis. J Appl Microbiol 119:981-990 https://doi.org/10.1111/jam.12906
  22. Torres JI, Perez-Perez G, Goodman KJ, Atherton JC, Gold BD, Harris PR, la Garza AM, Guarner J, Munoz O. 2000. A comprehensive review of Helicobacter pylori the natural history of infection in children. Arch Med Res 31:431-469 https://doi.org/10.1016/S0188-4409(00)00099-0